$EAPH Recent Headlines Easton Pharmaceuticals Pr
Post# of 72711
Posted On: 01/13/2014 3:25:58 PM
$EAPH Recent Headlines
Easton Pharmaceuticals Provides Update on Initiatives Towards Its Cancer Drug "Xilive" and Its Mexican Government Regulatory Filing Submission for "Viorra" 11:56 a.m. Dec. 11, 2013 - Marketwire
Easton Pharmaceuticals Enters Into Cancer Drug Industry by Acquiring Initial Minority Ownership Interest in Experimental Cancer Drug "XILIVE" With 12 Month Option to Purchase Remaining Interest; Preliminary Feedback Extremely Promising 1:39 p.m. Nov. 6, 2013 - Marketwire
Easton Pharmaceuticals Is Provided a Manufacturing, Regulatory Filing Update and Forward Sales Estimates for VIORRA 8:31 a.m. Nov. 4, 2013 - Marketwire
Easton Pharmaceuticals Announces Formal Agreement & Advances Payment to BMV Medica S.A. Towards a Regulatory Filing in Mexico for "Viorra"; Company Anticipates Approval and Initial Sales by End of Second Quarter 2014 7:03 a.m. Oct. 22, 2013 - Marketwire
Easton Pharmaceuticals Announces Application to Obtain a Distributorship License Towards Its Canadian Medical Marijuana Initiatives 7:01 a.m. Oct. 4, 2013 - Marketwire
Easton Pharmaceuticals Signs LOI to Acquire a Cosmetic Anti-Aging and Beauty Care Line of Products Including a Product to Compliment its Medical Marijuana Initiatives 8:00 a.m. Sept. 27, 2013 - BusinessWire
Easton Pharmaceuticals Re- Enters Drug Market, Acquires 50% Ownership Interest In FSAD Drug And Related Patents / Patent Pendings. Drug Subsequently Underwent Clinical Trials At Cedar-Sinai Medical Center, Beverley Hills, CA. 8:00 a.m. Sept. 16, 2013 - BusinessWire
Easton Pharmaceuticals, Inc. Provides Update on Its Medical Marijuana Initiatives 7:40 a.m. Aug. 23, 2013 - Filing Services Canada
Easton Pharmaceuticals, Inc. Provides Update on Its Medical Marijuana Initiatives 7:40 a.m. Aug. 23, 2013 - BusinessWire
Easton Pharmaceuticals Announces It Has Ordered Ingredients towards Producing Final Test and Trial Samples of Its Re-Formulated Viorra and Other Recently Added Portfolio Products 10:57 a.m. Aug. 14, 2013 - BusinessWire
Easton Pharmaceuticals Announces Three New Additional Products and a Revision to Its Viorra Flagship Product Towards Resuming Its Latin American & South East Asia Initiatives 6:09 p.m. June 7, 2013 - BusinessWire
Easton Pharmaceuticals, Inc. Announces Its Entrance into the Medical Marijuana Sector 3:25 p.m. June 5, 2013 - BusinessWire
Easton Pharmaceuticals Announces Neil Mellor as Senior Consultant, Chief Operations Officer 10:21 a.m. June 5, 2013 - BusinessWire
Easton Pharmaceuticals Announces Neil Mellor as Senior Consultant, Chief Operations Officer 4:57 p.m. June 4, 2013 - BusinessWire
Easton Pharmaceuticals Provides Corporate Update 2:09 p.m. April 9, 2013 - BusinessWire
Easton Pharmaceuticals Provides Corporate Update 7:30 a.m. April 9, 2013 - BusinessWire
Easton Pharmaceuticals Provides Update on Initiatives Towards Its Cancer Drug "Xilive" and Its Mexican Government Regulatory Filing Submission for "Viorra" 11:56 a.m. Dec. 11, 2013 - Marketwire
Easton Pharmaceuticals Enters Into Cancer Drug Industry by Acquiring Initial Minority Ownership Interest in Experimental Cancer Drug "XILIVE" With 12 Month Option to Purchase Remaining Interest; Preliminary Feedback Extremely Promising 1:39 p.m. Nov. 6, 2013 - Marketwire
Easton Pharmaceuticals Is Provided a Manufacturing, Regulatory Filing Update and Forward Sales Estimates for VIORRA 8:31 a.m. Nov. 4, 2013 - Marketwire
Easton Pharmaceuticals Announces Formal Agreement & Advances Payment to BMV Medica S.A. Towards a Regulatory Filing in Mexico for "Viorra"; Company Anticipates Approval and Initial Sales by End of Second Quarter 2014 7:03 a.m. Oct. 22, 2013 - Marketwire
Easton Pharmaceuticals Announces Application to Obtain a Distributorship License Towards Its Canadian Medical Marijuana Initiatives 7:01 a.m. Oct. 4, 2013 - Marketwire
Easton Pharmaceuticals Signs LOI to Acquire a Cosmetic Anti-Aging and Beauty Care Line of Products Including a Product to Compliment its Medical Marijuana Initiatives 8:00 a.m. Sept. 27, 2013 - BusinessWire
Easton Pharmaceuticals Re- Enters Drug Market, Acquires 50% Ownership Interest In FSAD Drug And Related Patents / Patent Pendings. Drug Subsequently Underwent Clinical Trials At Cedar-Sinai Medical Center, Beverley Hills, CA. 8:00 a.m. Sept. 16, 2013 - BusinessWire
Easton Pharmaceuticals, Inc. Provides Update on Its Medical Marijuana Initiatives 7:40 a.m. Aug. 23, 2013 - Filing Services Canada
Easton Pharmaceuticals, Inc. Provides Update on Its Medical Marijuana Initiatives 7:40 a.m. Aug. 23, 2013 - BusinessWire
Easton Pharmaceuticals Announces It Has Ordered Ingredients towards Producing Final Test and Trial Samples of Its Re-Formulated Viorra and Other Recently Added Portfolio Products 10:57 a.m. Aug. 14, 2013 - BusinessWire
Easton Pharmaceuticals Announces Three New Additional Products and a Revision to Its Viorra Flagship Product Towards Resuming Its Latin American & South East Asia Initiatives 6:09 p.m. June 7, 2013 - BusinessWire
Easton Pharmaceuticals, Inc. Announces Its Entrance into the Medical Marijuana Sector 3:25 p.m. June 5, 2013 - BusinessWire
Easton Pharmaceuticals Announces Neil Mellor as Senior Consultant, Chief Operations Officer 10:21 a.m. June 5, 2013 - BusinessWire
Easton Pharmaceuticals Announces Neil Mellor as Senior Consultant, Chief Operations Officer 4:57 p.m. June 4, 2013 - BusinessWire
Easton Pharmaceuticals Provides Corporate Update 2:09 p.m. April 9, 2013 - BusinessWire
Easton Pharmaceuticals Provides Corporate Update 7:30 a.m. April 9, 2013 - BusinessWire
(0)
(0)Scroll down for more posts ▼